Fokam, J.; Bouba, Y.; Ajeh, R.A.; Guebiapsi, D.T.; Essamba, S.; Zeh Meka, A.F.; Lifanda, E.; Ada, R.A.; Yakouba, L.; Mbengono, N.B.;
et al. Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study. Biomedicines 2024, 12, 2083.
https://doi.org/10.3390/biomedicines12092083
AMA Style
Fokam J, Bouba Y, Ajeh RA, Guebiapsi DT, Essamba S, Zeh Meka AF, Lifanda E, Ada RA, Yakouba L, Mbengono NB,
et al. Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study. Biomedicines. 2024; 12(9):2083.
https://doi.org/10.3390/biomedicines12092083
Chicago/Turabian Style
Fokam, Joseph, Yagai Bouba, Rogers Awoh Ajeh, Dominik Tameza Guebiapsi, Suzane Essamba, Albert Franck Zeh Meka, Ebiama Lifanda, Rose Armelle Ada, Liman Yakouba, Nancy Barbara Mbengono,
and et al. 2024. "Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study" Biomedicines 12, no. 9: 2083.
https://doi.org/10.3390/biomedicines12092083
APA Style
Fokam, J., Bouba, Y., Ajeh, R. A., Guebiapsi, D. T., Essamba, S., Zeh Meka, A. F., Lifanda, E., Ada, R. A., Yakouba, L., Mbengono, N. B., Djomo, A. R. D., Tetang, S. N., Sosso, S. M., Babodo, J. C., Ambomo, O. F. N., Temgoua, E. M., Medouane, C., Atsinkou, S. N., Mvogo, J. L.,
... Zoung-Kanyi Bissek, A.-C.
(2024). Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study. Biomedicines, 12(9), 2083.
https://doi.org/10.3390/biomedicines12092083
